RxDoctor Payments Data

Cynthia Thomas, MD

Internal Medicine · Chicago, ILNPI 1043264823

Payments from drug & device makers

$1,408in general payments, 2019–2025

Across 61 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$283
  • Lilly USA, LLC$183
  • Koya Medical, Inc.$169
  • Exact Sciences$166
  • Phadia US Inc.$155
  • Novo Nordisk$127
  • plus $326 from 9 others

What the payments were for

  • Food & beverage$1,408100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,408 in reported general payments places this provider in the 80th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$40,726
Medicare patients
53
Services billed
405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide40$38,728
XareltoRivaroxaban22$17,145
SymbicortBudesonide/Formoterol Fumarate11$2,541
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen52$2,321
Potassium Chloride27$2,212
Gabapentin44$636
Alprazolam30$566
Albuterol Sulfate HfaAlbuterol Sulfate33$486
Triamcinolone Acetonide15$486
Montelukast Sodium54$484
ClopidogrelClopidogrel Bisulfate39$458
Pregabalin23$401
Diclofenac Potassium14$373
Levothyroxine Sodium42$367
Losartan Potassium28$348

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$183$38,72840 claims
AstraZenecaSymbicort$283$2,54111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →